Mankind Pharma has announced a favorable ruling in its tax litigation proceedings. Following an appeal against the State GST (Appeals) authority in Nagpur, the company successfully secured the dropping of a penalty amounting to INR 46,32,582/-. This penalty was originally imposed concerning the financial year 2020-21 under Section 73 of the CGST Act, 2017. The order confirming this dismissal was received on February 16, 2026, impacting neither operations nor financials.
Favorable Order Received in Tax Dispute
Mankind Pharma Limited has formally intimated the exchanges regarding a significant development in its ongoing tax matters. On February 16, 2026, the company received an Order-in-Appeal from the Joint Commissioner of State Tax, State GST (Appeals), Nagpur, Maharashtra. This order effectively overturns a prior assessment.
Details of Penalty Relief
The core of the development is the dropping of a substantial penalty that had been levied against the company. The specific penalty amount dismissed totals INR 46,32,582/-. This penalty stemmed from an order passed by the Deputy Commissioner of State Tax relating to the financial year 2020-21 under Section 73 of the Central Goods and Services Tax Act, 2017.
Timeline and Previous Action
Mankind Pharma had previously filed an appeal against the original order, which dated back to February 28, 2025. The latest appellate order, No. 02/286, dated February 16, 2026, confirmed the company’s position, leading to the immediate cessation of the demand for the penalty amount.
Impact Assessment
The company has confirmed that this resolution does not involve any breach or contravention of regulations. Furthermore, the impact of this outcome on the financial, operational, or other activities of the listed entity is deemed N.A. (Not Applicable), indicating no quantifiable monetary effect post-resolution.
Source: BSE
